By Maggie Fick and Jennifer Rigby LONDON (Reuters) -Drugmakers Bharat Biotech and GSK will cut the price of their malaria ...

Oxford researchers have developed programmable microcapsules to deliver vaccines in stages, potentially eliminating the need ...

Kennedy called on Gavi “to re-earn the public trust and to justify the $8 billion America has provided in funding since 2001, ...

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices. | The ...

Bharat Biotech and GSK plc will significantly reduce the price of their malaria vaccine, Mosquirix, to under $5 per dose by ...

Oxford researchers have developed programmable microcapsules to deliver vaccines in stages, potentially eliminating the need for booster shots and ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world's first malaria ...

When combined with seasonal malaria chemoprevention, the vaccine RTS,S has shown up to 75 per cent efficacy in preventing ...

Bharat Biotech and GSK have announced plans to reduce the price of their malaria vaccine, Mosquirix, to $5 per dose by 2028.

As the deadly grip of malaria continues to claim thousands of lives each year, a powerful shift is underway in Uganda—one ...

Bharat Biotech and GSK to reduce RTS,S malaria vaccine price to under $5 per dose by 2028, enhancing access for children in ...

Bharat Biotech has entered into partnership in 2021 to produce part of the malaria vaccine that has been developed by British ...